- Home
- MANU vs IRON Comparison
MANU vs IRON Comparison
Compare MANU & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MANU
- IRON
- Stock Information
- Founded
- MANU 1878
- IRON 2017
- Country
- MANU United Kingdom
- IRON United States
- Employees
- MANU N/A
- IRON N/A
- Industry
- MANU Services-Misc. Amusement & Recreation
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- MANU Consumer Discretionary
- IRON Health Care
- Exchange
- MANU Nasdaq
- IRON Nasdaq
- Market Cap
- MANU 2.2B
- IRON 1.8B
- IPO Year
- MANU 2012
- IRON N/A
- Fundamental
- Price
- MANU $18.33
- IRON $54.75
- Analyst Decision
- MANU Buy
- IRON Strong Buy
- Analyst Count
- MANU 2
- IRON 11
- Target Price
- MANU $20.75
- IRON $92.64
- AVG Volume (30 Days)
- MANU 469.0K
- IRON 423.3K
- Earning Date
- MANU 06-06-2025
- IRON 08-07-2025
- Dividend Yield
- MANU N/A
- IRON N/A
- EPS Growth
- MANU N/A
- IRON N/A
- EPS
- MANU N/A
- IRON N/A
- Revenue
- MANU $832,748,485.00
- IRON N/A
- Revenue This Year
- MANU $2.44
- IRON N/A
- Revenue Next Year
- MANU $3.26
- IRON N/A
- P/E Ratio
- MANU N/A
- IRON N/A
- Revenue Growth
- MANU N/A
- IRON N/A
- 52 Week Low
- MANU $12.05
- IRON $30.82
- 52 Week High
- MANU $19.65
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- MANU 54.95
- IRON 59.95
- Support Level
- MANU $16.67
- IRON $51.01
- Resistance Level
- MANU $19.65
- IRON $55.52
- Average True Range (ATR)
- MANU 0.67
- IRON 2.43
- MACD
- MANU -0.17
- IRON -0.02
- Stochastic Oscillator
- MANU 20.30
- IRON 88.42
About MANU Manchester United Ltd.
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, and sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which the majority of the revenue is generated including Commercial, Broadcasting, and Matchday.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.